Brief Summary
The purpose of this study is to determine if larger doses of radiation given over a shorter period of time, as compared to standard radiation therapya treatment that uses controlled doses of radiation to damage or kill cancer cells, given with chemotherapya cancer treatment that uses drugs to kill or slow the growth of cancer cells, while minimising damage to healthy cells and followed by immunotherapya treatment that uses a person's immune system to fight cancer is safe for participants.
Intervention/Treatment
- Drug: Paclitaxel.
- Drug: Carboplatin.
- Drug: Durvalumab
Inclusion Criteria
- Unresectable locally advancedat a late stage, far along Non-small cell lung carcinomacancer arising from tissues that line organs.
- Considered suitable to receive chemoradiation and immunotherapy.
- ECOG performance status 0-2.